Aroa Biosurgery
AROA Biosurgery Limited specializes in regenerative healing products for soft-tissue repair. It emphasizes the use of extracellular matrix (ECM) biomaterials in its offerings, giving it a niche position in the medical devices market. The company aims to improve healing outcomes and reduce healthcare costs, standing out through its innovative solutions and successful commercialization strategies.
Short position
Aroa Biosurgery (ASX:ARX) has 0.00% of its shares on issue reported as short positions as of 1 Oct 2026, or about 18 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.47% in August 2023. ARX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ARX community
Research Threads
Bull, bear, catalyst, and news-reaction posts tied directly to ARX.
Start the first ARX research thread
Anchor the conversation with a thesis, a catalyst, or a question worth debating.